6 Results for "

HN5

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "HN5" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-103441
CAS No.: 944342-90-9
Purity:  98.36%
Target:  

EGFR

Research Areas:  

Cancer

JNJ28871063 hydrochloride is an orally active, highly selective and ATP competitive pan-ErbB kinase inhibitor with IC50 values of 22 nM, 38 nM, and 21 nM for ErbB1, ErbB2, and ErbB4, respectively. JNJ28871063 hydrochloride inhibits phosphorylation of functionally important tyrosine residues in both EGFR and ErbB2. JNJ28871063 hydrochloride crosses the blood-brain barrier and has antitumor activity in human tumor xenograft models that overexpress EGFR and ErbB2 .
loading...
    loading...
Cat. No.: HY-117523
CAS No.: 149286-90-8
Synonyms: (Z)-Tyrphostin RG13022
Target:  

EGFR

Research Areas:  

Cancer

(Z)-RG-13022 is a tyrosine kinase (TK) inhibitor, which inhibits preferentially the TK activity of the EGF receptor and inhibits EGF-stimulated growth of cultured cells. (Z)-RG-13022 exerts an IC50 of 11 μM for DNA synthesis in the HN5 cells, which is 3 times more potent than (E)-RG-13022 (IC50=38 μM). (Z)-RG-13022 can be used for research of breast cancer cells .
loading...
    loading...
Cat. No.: HY-112420
CAS No.: 179248-61-4
Purity:  99.45%
Target:  

EGFR

Research Areas:  

Infection Metabolic Disease Cancer

EGFR/ErbB-2-IN-2 is a EGFR and ErbB inhibitor with IC50s of 0.017 μM, 0.08 μM, 1.91 μM for EGFR, ErbB-2 and ErbB-4 .
loading...
    loading...
Cat. No.: HY-103439
CAS No.: 1173023-85-2
Research Areas:  

Cancer

GW 583340 dihydrochloride is an orally active ErbB-2/EGFR tyrosine kinase inhibitor. GW 583340 dihydrochloride exhibits antitumor activity in xenograft models with EGFR overexpression or ErbB-2 overexpression. GW 583340 dihydrochloride is applicable to research related to head and neck cancer, breast cancer, and gastric cancer .
loading...
    loading...
Cat. No.: HY-103439A
CAS No.: 388082-81-3
Research Areas:  

Cancer

GW583340 is an orally active ErbB-2/EGFR tyrosine kinase inhibitor. GW583340 exhibits antitumor activity in xenograft models with EGFR overexpression or ErbB-2 overexpression. GW583340 is applicable to research related to head and neck cancer, breast cancer, and gastric cancer .
loading...
    loading...
Cat. No.: HY-123726
CAS No.: 231277-83-1
Target:  

EGFR

Research Areas:  

Cancer

ErbB-1/ErbB-2 tyrosine kinase-IN-1 is a dual ErbB-1/ErbB-2 tyrosine kinase inhibitor with IC50 values of 0.027 μM and 0.026 μM. ErbB-1/ErbB-2 tyrosine kinase-IN-1 targets the ATP binding region of ErbB-1 and ErbB-2 tyrosine kinases. ErbB-1/ErbB-2 tyrosine kinase-IN-1 inhibits cancer cells proliferation .
loading...
    loading...